NCT05035407 2025-12-02
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
University of Southern California
Samus Therapeutics, Inc.
Netherlands Working Group on Immunotherapy of Oncology
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Stanford University
Vanderbilt-Ingram Cancer Center
Washington University School of Medicine